Ingredion signs $1.475 billion term loan to help fund Tate & Lyle acquisition
Ingredion entered a $1.475 billion senior unsecured delayed draw term loan agreement with JPMorgan Chase Bank as administrative agent, dated June 24, 2026. The loans can fund the cash consideration for its offer to buy Tate & Lyle PLC, the repayment of certain Tate & Lyle debt, and acquisition fees and costs. The new debt adds to Ingredion's borrowing, and the loan is subject to covenants on leverage and interest coverage.
Key points
- Facility totals $1,475,000,000: a $500,000,000 Tranche A-1 and a $975,000,000 Tranche B-1, maturing three and five years after funding, respectively.
- Loans amortize quarterly at 5% per year of outstanding principal and can be prepaid without premium or penalty.
- Covenants include a maximum leverage ratio of 3.5 to 1.0 and a minimum interest coverage ratio of 3.5 to 1.0.
- Commitments terminate automatically on February 2, 2028, and the $2,750,000,000 tranche B commitment under the June 8, 2026 bridge facility remains outstanding.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 25, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.